A nurse is providing education of enoxaparin to a patient diagnosed with deep venous thrombosis. Which statement by the patient indicates understanding of the teaching?

"It eliminates the clotting factors."

"This medication will keep the blood clot from growing larger."

"This medication will decrease my risk for bleeding."

"I will get this medication in my veins."

Answer and Explanation

The Correct Answer is B

A. "It eliminates the clotting factors." - This statement suggests a misunderstanding of how enoxaparin works. Enoxaparin is a low molecular weight heparin that does not eliminate clotting factors but rather inhibits the activity of factor Xa, a key enzyme involved in the coagulation cascade. By inhibiting factor Xa, enoxaparin prevents the conversion of prothrombin to thrombin, thereby reducing the formation of fibrin clots. It does not eliminate existing clotting factors from the bloodstream.

B. "This medication will keep the blood clot from growing larger." - This statement demonstrates a correct understanding of enoxaparin's mechanism of action. Enoxaparin is an anticoagulant medication that works by preventing the enlargement of existing blood clots. By inhibiting the activity of factor Xa, enoxaparin prevents the conversion of prothrombin to thrombin, thereby reducing the formation of fibrin clots and preventing existing clots from growing larger.

C. "This medication will decrease my risk for bleeding." - This statement is incorrect. Enoxaparin, like other anticoagulants, actually increases the risk of bleeding due to its mechanism of action. By inhibiting the coagulation cascade, enoxaparin prolongs the time it takes for blood to clot, which can lead to an increased risk of bleeding, particularly in patients who are predisposed to bleeding or are taking other medications that affect clotting.

D. "I will get this medication in my veins." - This statement is incorrect. Enoxaparin is administered subcutaneously, not intravenously. It is usually injected into the fatty tissue of the abdomen or thigh using a prefilled syringe with a short, thin needle. The subcutaneous route of administration allows for slow absorption and sustained anticoagulant effects over time.

Nursing Test Bank

Quiz #1: RN Exams Pharmacology Exams Quiz #2: RN Exams Medical-Surgical Exams Quiz #3: RN Exams Fundamentals Exams Quiz #4: RN Exams Maternal-Newborn Exams Quiz #5: RN Exams Anatomy and Physiology Exams Quiz #6: RN Exams Obstetrics and Pediatrics Exams Quiz #7: RN Exams Fluid and Electrolytes Exams Quiz #8: RN Exams Community Health Exams Quiz #9: RN Exams Promoting Health across the lifespan Exams Quiz #10: RN Exams Multidimensional care Exams

Get 100+ Naxlex Exit Exams for $79 Try Naxlex NCLEX-RN (14 Day Free-Trial)

Naxlex Comprehensive Predictor Exams

Quiz #1: Naxlex RN Comprehensive online practice 2019 B with NGN Quiz #2: Naxlex RN Comprehensive Predictor 2023 Quiz #3: Naxlex RN Comprehensive Predictor 2023 Exit Exam A Quiz #4: Naxlex HESI Exit LPN Exam Quiz #5: Naxlex PN Comprehensive Predictor PN 2020 Quiz #6: Naxlex VATI PN Comprehensive Predictor 2020 Quiz #8: Naxlex PN Comprehensive Predictor 2023 - Exam 1 Quiz #10: Naxlex HESI PN Exit exam Quiz #11: Naxlex HESI PN EXIT Exam 2

Free Nursing Study Resources

Correct Answer is B

Explanation

A. Diarrhea: Diarrhea is not a common side effect of metoprolol, a beta-blocker medication commonly used to treat hypertension. While gastrointestinal side effects such as nausea or constipation may occur, diarrhea is not typically associated with metoprolol use.

B. Insomnia: Insomnia, or difficulty falling or staying asleep, is a potential side effect of metoprolol. Beta-blockers like metoprolol may interfere with sleep patterns in some individuals, leading to insomnia. It is important for the nurse to assess the patient for changes in sleep patterns while taking metoprolol.

C. Urinary retention: Urinary retention, or the inability to completely empty the bladder, is not a common side effect of metoprolol. In fact, beta-blockers like metoprolol are more likely to cause urinary frequency or urgency rather than retention.

D. Gum changes: Gum changes, such as gingival hyperplasia, are not typically associated with metoprolol use. This side effect is more commonly associated with certain other medications, such as calcium channel blockers or anticonvulsants.

A. Let your provider know if a new cough occurs B. Take the medication on a full stomach C. This medication will not cause edema D. Eat a high potassium diet

Correct Answer is A

Explanation

A. Let your provider know if a new cough occurs:
This teaching is essential because lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is associated with a potential side effect of a persistent, dry cough. Notifying the healthcare provider if a new cough develops allows for appropriate management, such as discontinuation or adjustment of the medication to alleviate the symptom.

B. Take the medication on a full stomach:
Taking lisinopril with or without food is acceptable, as it does not significantly affect its absorption. However, taking it on an empty stomach is often recommended to optimize absorption. Advising the patient to take the medication on a full stomach is incorrect and may lead to misunderstandings.

C. This medication will not cause edema:
Lisinopril, as an ACE inhibitor, may actually cause or exacerbate edema as a side effect. It can lead to vasodilation and fluid retention, particularly in susceptible individuals. Providing incorrect information about the medication's potential side effects can compromise patient understanding and safety.

D. Eat a high potassium diet:
Lisinopril can increase serum potassium levels, so instructing the patient to consume a high-potassium diet may exacerbate this effect and lead to hyperkalemia. While dietary potassium intake should be monitored, advising a high-potassium diet without proper guidance can pose risks to the patient's health.

View Question and Answer

Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.

Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today

A nurse is providing education of enoxaparin to a patient diagnosed with deep venous thrombosis. Which statement by the patient indicates understanding of the teaching?

Nursing Test Bank

Naxlex Comprehensive Predictor Exams

The nurse is caring for a patient who has been taking metoprolol as a second medication to control hypertension. The nurse will assess for which side effect?

Correct Answer is B

Explanation

The nurse is caring for a patient who was recently placed on lisinopril to control hypertension. What teaching will the nurse provide?

Correct Answer is A

Explanation

A nurse is caring for a patient who is returning for a repeat blood pressure to determine if white coat syndrome occurred during the first clinical visit. Which diagnostic test will be used to confirm a diagnosis of hypertension?

The nurse is teaching a patient, newly diagnosed with primary hypertension, about the recommended blood pressure range needed to prevent organ damage. Which range, chosen by patient, indicates that the teaching was successful?

The nurse is assessing a patient diagnosed with hypertension several years ago. What assessment finding may indicate that target organ damage is now occurring?

A nurse is developing a discharge teaching plan for a patient diagnosed with peripheral arterial disease. Which instruction will the nurse include in the plan?

A nurse is assessing a patient who has a history of human immunodeficiency virus (HIV) and has been admitted with pneumonia. Which intervention will the nurse perform to ensure the patient exhibits clear breath sounds?

The nurse is caring for a patient who has a venous leg ulcer. The patient asks why these ulcers occur. What will the nurse explain as the cause for the development of venous ulcers?